Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Oct 8, 2017
PlasmaVigilance: Source Plasma Donor Hemovigilance Activities and Results
Source plasma donor hemovigilance activities and results.
All
Presentation
https://plasmaprotein.sharepoint.com/:p:/s/MR/EagLfeqXKSFEgPK2frz5bfYBXEMg7uThOs4wXek-L66Scw?e=fQg7u3
Oct 8, 2017
PlasmaVigilance: Source Plasma Donor Hemovigilance Activities and Results
Source plasma donor hemovigilance activities and results.
All
Presentation
https://plasmaprotein.sharepoint.com/:p:/s/MR/EagLfeqXKSFEgPK2frz5bfYBXEMg7uThOs4wXek-L66Scw?e=fQg7u3
Sep 1, 2017
The Source Fall 2017
Magazine of the plasma protein therapeutics industry - Fall 2017
All
The Source Magazine
https://drive.google.com/file/d/1HK0SmJb-NAd5qO-CKdLG8BBYyjP1u__P/view?usp=sharing
Sep 1, 2017
The Source Fall 2017
Magazine of the plasma protein therapeutics industry - Fall 2017
All
The Source Magazine
https://drive.google.com/file/d/1HK0SmJb-NAd5qO-CKdLG8BBYyjP1u__P/view?usp=sharing
Jun 1, 2017
The Source Summer 2017
Magazine of the plasma protein therapeutics industry - Summer 2017
All
The Source Magazine
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/644fcd784edd3c1d77b17524_TheSource_Summer2017.pdf
Jun 1, 2017
The Source Summer 2017
Magazine of the plasma protein therapeutics industry - Summer 2017
All
The Source Magazine
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/644fcd784edd3c1d77b17524_TheSource_Summer2017.pdf
May 16, 2017
Plasma protein product safety and Creutzfeldt-Jakob disease (CJD)
A recent publication in the Emerging Infectious Diseases journal (published online on June 12, 2017) describes two individuals with bleeding disorders who were diagnosed with sporadic Creutzfeldt-Jakob disease (sCJD) (1). The authors of this scientific report have not established a causal link between the treatment with clotting factors and the development of sporadic CJD and concluded that “the occurrence of these cases may simply reflect a chance event in the context of systematic surveillance for CJD in large populations”.
All
PPTA statements
May 16, 2017
Plasma protein product safety and Creutzfeldt-Jakob disease (CJD)
A recent publication in the Emerging Infectious Diseases journal (published online on June 12, 2017) describes two individuals with bleeding disorders who were diagnosed with sporadic Creutzfeldt-Jakob disease (sCJD) (1). The authors of this scientific report have not established a causal link between the treatment with clotting factors and the development of sporadic CJD and concluded that “the occurrence of these cases may simply reflect a chance event in the context of systematic surveillance for CJD in large populations”.
All
PPTA statements
No results found